Cytosorbents Corp. Stock
Cytosorbents Corp. Stock
Cytosorbents Corp. dominated the market today, gaining €0.020 (3.740%).
With 11 Buy predictions and not the single Sell prediction the community is currently very high on Cytosorbents Corp..
Based on the current price of 0.52 € the target price of 8 € shows a potential of 1438.46% for Cytosorbents Corp. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Cytosorbents Corp. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Cytosorbents Corp. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cytosorbents Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cytosorbents Corp. | 3.740% | 1.961% | -24.198% | -40.092% | -9.722% | -82.131% | -93.015% |
| Simulations Plus | 10.000% | 19.802% | 14.151% | -67.297% | -21.429% | -67.297% | -76.731% |
| Fonar Corp. New | 0.000% | -1.250% | 0.000% | 42.342% | 1.282% | 8.966% | 3.268% |
| MicroVision Inc | -3.360% | -5.537% | 8.187% | -50.652% | -30.149% | -76.774% | -95.628% |
Comments
Cytosorbents (CTSO) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $10.00 price target on the stock.
Show more
Ratings data for CTSO provided by MarketBeat
Cytosorbents (NASDAQ:CTSO) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.
Show more
Ratings data for CTSO provided by MarketBeat
Cytosorbents (NASDAQ:CTSO) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.
Show more
Ratings data for CTSO provided by MarketBeat